What ASCs need to know about monkeypox: 8 notes

With hospitals bracing themselves for more monkeypox cases, ASCs should also be prepared for the infectious disease to surge. 

Advertisement

From vaccines to testing, ASCs should expect to play a role in curbing the public health emergency.  

Eight things ASCs need to know about monkeypox: 

1. Monkeypox appears to be less infectious than other viruses, including COVID-19 and smallpox, with the chance of spreading it to a fellow household member at around 0.6 percent. The chance of spreading COVID-19 to another member of a household is about 40 percent. 

2. The case fatality rate has been between 3 percent and 6 percent, with symptoms lasting for two to four weeks for the infected.

3. The number of confirmed cases in the U.S. is over 10,000. 

4. The FDA has approved the Jynneos monkeypox vaccine for high risk children under 18.

5. Diagnostic lab company Provista has entered two contracts to provide PCR monkeypox testing. 

6. As of an Aug. 8 report, the CDC has the capacity to perform 80,000 tests per week, and currently conducts about 8,000. 

7. The U.S. has seen five pediatric cases of the virus, and has the most cases of any nation. 

8. The outbreak is currently most prevalent among men who have sex with men.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in ASC News

Advertisement

Comments are closed.